Effect of Botulinum Toxin Type A on Functional Mobility in Cerebral Palsy with Lower Limb Spasticity

Introduction: Children with Cerebral Palsy (CP) often start walking much later than typically developing children and they do so with a slower speed and higher energy cost. Mobility varies across different environmental settings and Functional Mobility Scale (FMS) was devised to illustrate functiona...

Full description

Bibliographic Details
Main Authors: Abhimanyu Vasudeva, Nonica Laisram, Asem Rangita Chanu
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2018-05-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/11554/34639_CE[Ra]_F(Sh)_PF1(A_SL)_PFA(A_SHU_SL)_PN(SS).pdf
_version_ 1818789769279176704
author Abhimanyu Vasudeva
Nonica Laisram
Asem Rangita Chanu
author_facet Abhimanyu Vasudeva
Nonica Laisram
Asem Rangita Chanu
author_sort Abhimanyu Vasudeva
collection DOAJ
description Introduction: Children with Cerebral Palsy (CP) often start walking much later than typically developing children and they do so with a slower speed and higher energy cost. Mobility varies across different environmental settings and Functional Mobility Scale (FMS) was devised to illustrate functional mobility in these children over three distinct distances, chosen to represent mobility in the home, at school and in the wider community. Botulinum toxin A injections into the gastrocnemius muscle for equinus foot deformity, as well as multilevel lower limb injections have shown improvements in gait, however, there is paucity of literature on its effect on functional mobility. Aim: To study the efficacy of Botulinum toxin A injection in CP with lower limb spasticity in terms of reduction in spasticity and effect on functional mobility. Materials and Methods: A total of 31 children were enrolled and evaluated for various outcome measures just before injection and at 4 and 12 weeks after injection. Change in FMS on follow-up was analysed using Wilcoxon signed-rank test. Spearman’s correlation analysis was performed between the number of injected muscles in each child and change in FMS scores on follow-up. A p-value of <0.05 was considered statistically significant. Analyses were done using SPSS version 21.0 statistical software (IBM Corp., Armonk, NY). Results: At distances of 5, 50 and 500 meters, FMS showed statistically significant improvement at four weeks (p-value <0.001 at 5; 0.002 at 50; 0.006 at 500 meters) and at 12 weeks (p-value <0.001 at 5; 0.001 at 50; 0.002 at 500 meters) compared with baseline but no significant change from 4 to 12 weeks (p-value=0.102 at 5; 1.000 at 50; 0.157 at 500 meters). There was moderate positive correlation between the number of injected muscles in each child and the change in FMS from baseline to 12 weeks at 5 meters distance; however, a moderate negative correlation was observed for the same at 500 meters. Conclusion: Local injection of Botulinum toxin A is effective in reducing the lower limb (gastrocnemius, hamstring, adductor) spasticity in CP children. It also improves the FMS in CP children.
first_indexed 2024-12-18T14:44:49Z
format Article
id doaj.art-ac287ce30897490caf6269fd95a9a183
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-18T14:44:49Z
publishDate 2018-05-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-ac287ce30897490caf6269fd95a9a1832022-12-21T21:04:17ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2018-05-01125YC05YC0910.7860/JCDR/2018/34639.11554Effect of Botulinum Toxin Type A on Functional Mobility in Cerebral Palsy with Lower Limb SpasticityAbhimanyu Vasudeva0Nonica Laisram1Asem Rangita Chanu2Senior Resident, Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences, New Delhi, India.Consultant, Professor and Head, Department of Physical Medicine and Rehabilitation, Vardhman, Mahavir Medical College and Safdarjung Hospital, New Delhi, India.Assistant Professor, Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences, New Delhi, India.Introduction: Children with Cerebral Palsy (CP) often start walking much later than typically developing children and they do so with a slower speed and higher energy cost. Mobility varies across different environmental settings and Functional Mobility Scale (FMS) was devised to illustrate functional mobility in these children over three distinct distances, chosen to represent mobility in the home, at school and in the wider community. Botulinum toxin A injections into the gastrocnemius muscle for equinus foot deformity, as well as multilevel lower limb injections have shown improvements in gait, however, there is paucity of literature on its effect on functional mobility. Aim: To study the efficacy of Botulinum toxin A injection in CP with lower limb spasticity in terms of reduction in spasticity and effect on functional mobility. Materials and Methods: A total of 31 children were enrolled and evaluated for various outcome measures just before injection and at 4 and 12 weeks after injection. Change in FMS on follow-up was analysed using Wilcoxon signed-rank test. Spearman’s correlation analysis was performed between the number of injected muscles in each child and change in FMS scores on follow-up. A p-value of <0.05 was considered statistically significant. Analyses were done using SPSS version 21.0 statistical software (IBM Corp., Armonk, NY). Results: At distances of 5, 50 and 500 meters, FMS showed statistically significant improvement at four weeks (p-value <0.001 at 5; 0.002 at 50; 0.006 at 500 meters) and at 12 weeks (p-value <0.001 at 5; 0.001 at 50; 0.002 at 500 meters) compared with baseline but no significant change from 4 to 12 weeks (p-value=0.102 at 5; 1.000 at 50; 0.157 at 500 meters). There was moderate positive correlation between the number of injected muscles in each child and the change in FMS from baseline to 12 weeks at 5 meters distance; however, a moderate negative correlation was observed for the same at 500 meters. Conclusion: Local injection of Botulinum toxin A is effective in reducing the lower limb (gastrocnemius, hamstring, adductor) spasticity in CP children. It also improves the FMS in CP children.https://jcdr.net/articles/PDF/11554/34639_CE[Ra]_F(Sh)_PF1(A_SL)_PFA(A_SHU_SL)_PN(SS).pdfcerebral palsyfunctional mobility scalespasticity
spellingShingle Abhimanyu Vasudeva
Nonica Laisram
Asem Rangita Chanu
Effect of Botulinum Toxin Type A on Functional Mobility in Cerebral Palsy with Lower Limb Spasticity
Journal of Clinical and Diagnostic Research
cerebral palsy
functional mobility scale
spasticity
title Effect of Botulinum Toxin Type A on Functional Mobility in Cerebral Palsy with Lower Limb Spasticity
title_full Effect of Botulinum Toxin Type A on Functional Mobility in Cerebral Palsy with Lower Limb Spasticity
title_fullStr Effect of Botulinum Toxin Type A on Functional Mobility in Cerebral Palsy with Lower Limb Spasticity
title_full_unstemmed Effect of Botulinum Toxin Type A on Functional Mobility in Cerebral Palsy with Lower Limb Spasticity
title_short Effect of Botulinum Toxin Type A on Functional Mobility in Cerebral Palsy with Lower Limb Spasticity
title_sort effect of botulinum toxin type a on functional mobility in cerebral palsy with lower limb spasticity
topic cerebral palsy
functional mobility scale
spasticity
url https://jcdr.net/articles/PDF/11554/34639_CE[Ra]_F(Sh)_PF1(A_SL)_PFA(A_SHU_SL)_PN(SS).pdf
work_keys_str_mv AT abhimanyuvasudeva effectofbotulinumtoxintypeaonfunctionalmobilityincerebralpalsywithlowerlimbspasticity
AT nonicalaisram effectofbotulinumtoxintypeaonfunctionalmobilityincerebralpalsywithlowerlimbspasticity
AT asemrangitachanu effectofbotulinumtoxintypeaonfunctionalmobilityincerebralpalsywithlowerlimbspasticity